ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $3.51 billion. The enterprise value is $4.56 billion.
| Market Cap | 3.51B |
| Enterprise Value | 4.56B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.99 million shares outstanding. The number of shares has increased by 2.44% in one year.
| Current Share Class | 24.99M |
| Shares Outstanding | 24.99M |
| Shares Change (YoY) | +2.44% |
| Shares Change (QoQ) | +2.01% |
| Owned by Insiders (%) | 1.92% |
| Owned by Institutions (%) | 103.17% |
| Float | 24.51M |
Valuation Ratios
The trailing PE ratio is 75.79 and the forward PE ratio is 56.53. ICU Medical's PEG ratio is 5.95.
| PE Ratio | 75.79 |
| Forward PE | 56.53 |
| PS Ratio | 1.63 |
| Forward PS | 1.60 |
| PB Ratio | 1.66 |
| P/TBV Ratio | 128.05 |
| P/FCF Ratio | 42.42 |
| P/OCF Ratio | 20.95 |
| PEG Ratio | 5.95 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.64, with an EV/FCF ratio of 55.13.
| EV / Earnings | 98.39 |
| EV / Sales | 2.11 |
| EV / EBITDA | 14.64 |
| EV / EBIT | 41.40 |
| EV / FCF | 55.13 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.64.
| Current Ratio | 2.34 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 4.08 |
| Debt / FCF | 16.25 |
| Interest Coverage | 1.27 |
Financial Efficiency
Return on equity (ROE) is 2.26% and return on invested capital (ROIC) is 3.48%.
| Return on Equity (ROE) | 2.26% |
| Return on Assets (ROA) | 1.68% |
| Return on Invested Capital (ROIC) | 3.48% |
| Return on Capital Employed (ROCE) | 3.15% |
| Weighted Average Cost of Capital (WACC) | 7.58% |
| Revenue Per Employee | $165,907 |
| Profits Per Employee | $3,565 |
| Employee Count | 13,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.24 |
Taxes
| Income Tax | -36.85M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.00% in the last 52 weeks. The beta is 0.78, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +8.00% |
| 50-Day Moving Average | 129.23 |
| 200-Day Moving Average | 134.89 |
| Relative Strength Index (RSI) | 58.52 |
| Average Volume (20 Days) | 299,362 |
Short Selling Information
The latest short interest is 1.84 million, so 7.35% of the outstanding shares have been sold short.
| Short Interest | 1.84M |
| Short Previous Month | 1.63M |
| Short % of Shares Out | 7.35% |
| Short % of Float | 7.50% |
| Short Ratio (days to cover) | 5.92 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.16 billion and earned $46.34 million in profits. Earnings per share was $1.85.
| Revenue | 2.16B |
| Gross Profit | 818.16M |
| Operating Income | 110.13M |
| Pretax Income | 9.49M |
| Net Income | 46.34M |
| EBITDA | 311.45M |
| EBIT | 110.13M |
| Earnings Per Share (EPS) | $1.85 |
Balance Sheet
The company has $292.68 million in cash and $1.34 billion in debt, with a net cash position of -$1.05 billion or -$42.05 per share.
| Cash & Cash Equivalents | 292.68M |
| Total Debt | 1.34B |
| Net Cash | -1.05B |
| Net Cash Per Share | -$42.05 |
| Equity (Book Value) | 2.11B |
| Book Value Per Share | 84.50 |
| Working Capital | 695.34M |
Cash Flow
In the last 12 months, operating cash flow was $167.43 million and capital expenditures -$84.72 million, giving a free cash flow of $82.71 million.
| Operating Cash Flow | 167.43M |
| Capital Expenditures | -84.72M |
| Depreciation & Amortization | 201.32M |
| Net Borrowing | -261.75M |
| Free Cash Flow | 82.71M |
| FCF Per Share | $3.31 |
Margins
Gross margin is 37.93%, with operating and profit margins of 5.11% and 2.15%.
| Gross Margin | 37.93% |
| Operating Margin | 5.11% |
| Pretax Margin | 0.44% |
| Profit Margin | 2.15% |
| EBITDA Margin | 14.44% |
| EBIT Margin | 5.11% |
| FCF Margin | 3.83% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.44% |
| Shareholder Yield | -2.44% |
| Earnings Yield | 1.32% |
| FCF Yield | 2.36% |
Analyst Forecast
The average price target for ICU Medical is $172.50, which is 22.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $172.50 |
| Price Target Difference | 22.89% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 2.06% |
| EPS Growth Forecast (3Y) | 9.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
ICU Medical has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.14 |
| Piotroski F-Score | 6 |